What's behind the FDA's controversial strategy for evaluating new COVID boosters
Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.
Read more on NPR
Science - August 18, 2022 at 04:04PM - What's behind the FDA's controversial strategy for evaluating new COVID boosters
Không có nhận xét nào:
Đăng nhận xét